[Challenges and perspectives of antiplatelet therapy in the secondary prevention of vascular events]

Rev Neurol. 2010 Jan;50(1):59-61.
[Article in Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Aspirin / therapeutic use
  • Clinical Trials as Topic
  • Clopidogrel
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Secondary Prevention*
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use
  • Treatment Outcome
  • Vascular Diseases* / drug therapy
  • Vascular Diseases* / prevention & control

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin